SCHEMBL6566906

SCHEMBL6566906

O=C(Nc1cc(Cl)c(O)c(Cl)c1)C(c1ccccc1)c1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.66
TACR1 P25103 1/20 0.59
KMT2A Q03164 8/20 0.58
MEN1 O00255 7/20 0.58
ALDH1A1 P00352 4/20 0.58
MAPT P10636 3/20 0.58
S1PR3 Q99500 2/20 0.58
LMNA P02545 1/20 0.58
TP53 P04637 1/20 0.58
HTR1E P28566 1/20 0.58
HTT P42858 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
GAA P10253 2/20 0.54
DHODH Q02127 1/20 0.51
NPY2R P49146 2/20 0.51
HDAC3 O15379 1/20 0.50
HDAC4 P56524 1/20 0.50
HDAC1 Q13547 1/20 0.50
HDAC7 Q8WUI4 1/20 0.50
HDAC2 Q92769 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1383257 0.80 POLB (1.00) POLBTACR1KMT2AMEN1MAPT
SCHEMBL13949529 0.80 MEN1 (0.66) POLBTACR1KMT2AMEN1ALDH1A1
SCHEMBL4342381 0.77 KMT2A (0.68) POLBKMT2AMEN1MAPTLMNA
SCHEMBL10954177 0.76 POLB (0.76) POLBKMT2AMEN1ALDH1A1MAPT
SCHEMBL4341392 0.76 NPC1 (0.70) KMT2AMEN1MAPTLMNAHTT
SCHEMBL6567231 0.75 MEN1 (0.50) TACR1KMT2AMEN1ALDH1A1MAPT
SCHEMBL13166707 0.74 NPY2R (0.77) POLBKMT2AMEN1ALDH1A1MAPT
SCHEMBL1706750 0.74 DHODH (0.54) POLBKMT2AMEN1ALDH1A1MAPT
SCHEMBL6568615 0.73 ROCK2 (0.54) LMNAL3MBTL1DHODHKDM4ESMN1; SMN2
SCHEMBL23715874 0.72 POLB (0.76) POLBTACR1KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1402887-A1 New compounds for the inhibition of undesired cell proliferation and use thereof Jerini AG (DE) 2004-03-31 EP claimed
EP-1402888-A1 The use of substituted carbocyclic compounds as rotamases inhibitors Jerini AG (DE) 2004-03-31 EP claimed